$PODD
INSULET CORP Stock $podd

$podd Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000114519714000013 Filed on February 28, 2014

Income Statement

Concept	2014 Q1	2013	2012 Q4
Revenue	$55.35M	$185.1M	$57.83M
YoY Change	-3.49%	-12.41%	22.54%
Cost Of Revenue	$36.35M	$95.36M	$32.50M
YoY Change	12.89%	-19.88%	19.93%
Gross Profit	$28.43M	$89.78M	$25.32M
YoY Change	13.04%	-2.77%	26.09%
Gross Profit Margin	51.37%	48.49%	43.78%
Selling, General & Admin	$27.92M	$94.69M	$25.60M
YoY Change	3.52%	-8.91%	22.49%
% of Gross Profit	98.17%	105.47%	101.11%
Research & Development	$6.779M	$21.77M	$5.800M
YoY Change	54.21%	-10.65%	0.0%
% of Gross Profit	23.84%	24.24%	22.91%
Depreciation & Amortization	$3.070M	$11.81M	$2.940M
YoY Change	5.72%	7.04%	4.26%
% of Gross Profit	10.8%	13.15%	11.61%
Operating Expenses	$34.69M	$116.5M	$31.40M
YoY Change	10.63%	-9.24%	2.61%
Operating Profit	-$1.886M	-$26.68M	-$6.081M
YoY Change	-69.61%	-25.84%	-42.2%
Interest Expense	$300.0K	-$15.40M	-$4.000M
YoY Change		-1.91%	8.11%
% of Operating Profit
Other Income/Expense, Net	-$4.193M	-$15.78M
YoY Change	-3.12%	0.63%
Pretax Income	-$6.079M	-$42.46M	-$10.10M
YoY Change	-42.29%	-17.8%	-28.87%
Income Tax	$65.00K	$22.00K	$100.0K
% Of Pretax Income
Net Earnings	-$6.144M	-$44.97M	-$10.19M
YoY Change	-42.39%	-13.29%	-28.9%
Net Earnings / Revenue	-11.1%	-24.29%	-17.63%
Basic Earnings Per Share
Diluted Earnings Per Share	-$110.7K	-$833.3K	-$211.6K
COMMON SHARES
Basic Shares Outstanding	55.06M shares		48.16M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$145.6M	$149.7M	$57.30M
YoY Change	-1.69%	161.26%	-39.04%
Cash & Equivalents	$146.4M	$149.7M	$57.29M
Short-Term Investments
Other Short-Term Assets	$7.100M	$5.900M	$4.500M
YoY Change	10.94%	31.11%	21.62%
Inventory	$10.45M	$9.500M	$14.87M
Prepaid Expenses
Receivables	$36.68M	$33.10M	$33.29M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$199.9M	$198.2M	$109.9M
YoY Change	2.62%	80.35%	-17.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.56M	$32.40M	$25.42M
YoY Change	30.32%	27.56%	30.89%
Goodwill	$37.54M		$37.54M
YoY Change	0.0%		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.652M	$1.800M	$2.202M
YoY Change	-19.65%	-18.18%	-19.25%
Total Long-Term Assets	$88.67M	$89.80M	$88.12M
YoY Change	2.94%	1.81%	-0.64%
TOTAL ASSETS
Total Short-Term Assets	$199.9M	$198.2M	$109.9M
Total Long-Term Assets	$88.67M	$89.80M	$88.12M
Total Assets	$288.5M	$288.0M	$198.1M
YoY Change	2.72%	45.38%	-10.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.98M	$19.40M	$9.361M
YoY Change	145.59%	106.38%	-18.02%
Accrued Expenses	$18.77M	$19.50M	$19.05M
YoY Change	4.16%	2.63%	45.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.800M	$2.600M	$14.43M
YoY Change	-81.0%	-81.94%
Total Short-Term Liabilities	$43.12M	$42.40M	$48.29M
YoY Change	0.32%	-12.22%	72.48%
LONG-TERM LIABILITIES
Long-Term Debt	$116.3M	$119.0M	$103.7M
YoY Change	9.5%	14.75%	-4.43%
Other Long-Term Liabilities	$1.984M	$1.900M	$1.867M
YoY Change	-9.24%	0.0%	-9.02%
Total Long-Term Liabilities	$118.3M	$120.9M	$105.6M
YoY Change	9.13%	14.49%	-4.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.12M	$42.40M	$48.29M
Total Long-Term Liabilities	$118.3M	$120.9M	$105.6M
Total Liabilities	$166.0M	$163.4M	$153.9M
YoY Change	9.7%	6.17%	11.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$532.7M		-$481.6M
YoY Change	8.22%		12.07%
Common Stock	$55.00K		$48.00K
YoY Change	3.77%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$122.5M	$124.6M	$44.18M
YoY Change
Total Liabilities & Shareholders Equity	$288.5M	$288.0M	$198.1M
YoY Change	2.72%	45.38%	-10.51%

Cashflow Statement

Concept	2014 Q1	2013	2012 Q4
OPERATING ACTIVITIES
Net Income	-$6.144M	-$44.97M	-$10.19M
YoY Change	-42.39%	-13.29%	-28.9%
Depreciation, Depletion And Amortization	$3.070M	$11.81M	$2.940M
YoY Change	5.72%	7.04%	4.26%
Cash From Operating Activities	-$1.017M	$3.348M	-$5.590M
YoY Change	-15.25%	-111.52%	-27.12%
INVESTING ACTIVITIES
Capital Expenditures	$2.157M	$7.307M	-$2.050M
YoY Change	101.78%	-33.52%	-9.69%
Acquisitions		$0.00
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities	-$2.157M	-$7.307M	-$2.050M
YoY Change	101.78%	-33.52%	-10.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$3.561M	$102.7M
YoY Change	-96.23%	1983.46%
Debt Paid & Issued, Net		$2.000M
YoY Change
Cash From Financing Activities	-$939.0K	$96.39M	1.500M
YoY Change	-101.01%	2745.13%	1775.0%
NET CHANGE
Cash From Operating Activities	-$1.017M	$3.348M	-5.590M
Cash From Investing Activities	-$2.157M	-$7.307M	-2.050M
Cash From Financing Activities	-$939.0K	$96.39M	1.500M
Net Change In Cash	-$4.113M	$92.43M	-6.140M
YoY Change	-104.53%	-352.12%	-37.79%
FREE CASH FLOW
Cash From Operating Activities	-$1.017M	$3.348M	-$5.590M
Capital Expenditures	$2.157M	$7.307M	-$2.050M
Free Cash Flow	-$3.174M	-$3.959M	-$3.540M
YoY Change	39.89%	-90.11%	-34.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	40200000	USD
CY2012Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	39921000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9361000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19359000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	8027000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9900000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33294000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33067000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19051000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19478000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2069000	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2437000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27927000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34462000	USD
CY2013	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P8Y
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	525679000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	651067000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	25915000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9862000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12616000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7683000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	5000000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7700000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12700000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7133000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6627000	USD
CY2011	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	9736000	USD
CY2012	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	10212000	USD
CY2013	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	10056000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4900000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000000	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	USD
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9671568	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9580353	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8328148	shares
CY2013	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2511000	USD
CY2011	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2012	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2013Q4	us-gaap	Assets Assets	287955000	USD
CY2012Q4	us-gaap	Assets Assets	198059000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	109936000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	198198000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	0	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	2637000	USD
CY2013	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	9021000	USD
CY2011	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2012	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5390000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	10039000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	3815000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	2409000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	3815000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	2012000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149727000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57293000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	113274000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93955000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	50251000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	128308000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-19319000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	92434000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-36662000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54870424	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48359063	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54870424	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48359063	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	55000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	48000	USD
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents. The Company maintains the majority of its cash with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> accredited financial institutions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company purchases complete OmniPods from Flextronics International Ltd., its single source supplier. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2012</font><font style="font-family:inherit;font-size:10pt;">, liabilities from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> vendor represented approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">36%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">19%</font><font style="font-family:inherit;font-size:10pt;"> of the combined balance of accounts payable, accrued expenses and other current liabilities, respectively.</font></div></div>
CY2011	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	85543000	USD
CY2013	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	13000000	USD
CY2012	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	119033000	USD
CY2013	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	134683000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	121000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16000	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	77000	USD
CY2012	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2011	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2013Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	13000000	USD
CY2013Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	26523	shares
CY2013Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	620122	shares
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	40591000	USD
CY2013Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	30099000	USD
CY2012Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2004000	USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	1414000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	91000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	84000	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11289000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5445000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	900000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	171066000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	177096000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	151818000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	154872000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	461700000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	404400000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	282800000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	217500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6357000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4661000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	9841000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	7608000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2679000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2602000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	158323000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	145927000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	223000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	139000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	15955000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	11214000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	223000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	139000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	6734000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	9015000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	515000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	169000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	310000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1000000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1000000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	USD
CY2013	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2012	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2011	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2013	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.25
CY2011	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.25
CY2012	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.25
CY2011	us-gaap	Depreciation Depreciation	4600000	USD
CY2012	us-gaap	Depreciation Depreciation	5000000	USD
CY2013	us-gaap	Depreciation Depreciation	6900000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11806000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8503000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11030000	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.08
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.98
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.83
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0040
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0022
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1966
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0018
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2932
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1165
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.3234
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0137
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0549
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0196
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0001
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0092
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0118
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0421
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0188
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0207
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0498
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0050
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6887000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6789000	USD
CY2013	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2013	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P2Y5M15D
CY2013	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.38
CY2013	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0056
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14860000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9937000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4151000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3977000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1806000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2190000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2665000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3251000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32900000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32900000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22963000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18040000	USD
CY2011	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	32900000	USD
CY2013Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	100000	USD
CY2012Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	300000	USD
CY2013Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	300000	USD
CY2013Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	200000	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44083000	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51240000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	64077000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	37536000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	37536000	USD
CY2013	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2011	us-gaap	Gross Profit GrossProfit	66712000	USD
CY2012	us-gaap	Gross Profit GrossProfit	92336000	USD
CY2013	us-gaap	Gross Profit GrossProfit	112401000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	33018000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	25155000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	27395000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	26833000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	22331000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	20296000	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	25319000	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	24390000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-44874000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-51655000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-57043000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11212000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	212000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	321000	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	263000	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	11000	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3617000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13513000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4514000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2863000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4545000	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1665000	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1879000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5403000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3029000	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1595000	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1671000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-185000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	76000	USD
CY2011	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	383000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	320000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	898000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-853000	USD
CY2013	us-gaap	Interest And Debt Expense InterestAndDebtExpense	17214000	USD
CY2011	us-gaap	Interest And Debt Expense InterestAndDebtExpense	14715000	USD
CY2012	us-gaap	Interest And Debt Expense InterestAndDebtExpense	15794000	USD
CY2012	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	600000	USD
CY2013	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	300000	USD
CY2011	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2013	us-gaap	Interest Paid InterestPaid	5704000	USD
CY2012	us-gaap	Interest Paid InterestPaid	6197000	USD
CY2011	us-gaap	Interest Paid InterestPaid	5173000	USD
CY2013Q2	us-gaap	Interest Paid InterestPaid	300000	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	258000	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	225000	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7394000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11785000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	9464000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	14867000	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	399000	USD
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1487000	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	110000	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	124000	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	139000	USD
CY2011	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1300000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1700000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1600000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	153883000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	163358000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	287955000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	198059000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42374000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	48286000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	118159000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	113651000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	14429000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	103730000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	113651000	USD
CY2013	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is primarily engaged in the development, manufacturing and sale of its proprietary OmniPod Insulin Management System (the “OmniPod System”), an innovative, discreet and easy-to-use insulin infusion system for people with insulin-dependent diabetes. The OmniPod System is the only commercially-available insulin infusion system of its kind. The OmniPod System features a unique disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the handheld, wireless Personal Diabetes Manager (“PDM”). Conventional insulin pumps require people with insulin-dependent diabetes to learn to use, manage and wear a number of cumbersome components, including up to 42 inches of tubing. In contrast, the OmniPod System features two discreet, easy-to-use devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2011, the Company acquired Neighborhood Holdings, Inc. and its wholly-owned subsidiaries (collectively, “Neighborhood Diabetes”) in order to expand the Company’s full suite diabetes management product offerings and obtain access to a larger number of insulin dependent patients. Through Neighborhood Diabetes, the Company is able to provide customers with blood glucose testing supplies, traditional insulin pumps, pump supplies and pharmaceuticals and has the ability to process claims as either durable medical equipment or through pharmacy benefits.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company began commercial sale of the OmniPod System in the United States in October 2005. The Company has also expanded the availability of the OmniPod System internationally through its partnership with Ypsomed Distribution AG (“Ypsomed”) and GlaxoSmithKline (“GSK”). In January 2010, the Company entered into a distribution agreement with Ypsomed pursuant to which Ypsomed became the exclusive distributor of the OmniPod System in multiple countries. In February 2011, the Company entered into a distribution agreement with GSK pursuant to which GSK became the exclusive distributor of the OmniPod System in Canada. In August 2011, the Company received CE Mark approval, and in December 2012, the Company received 510(k) clearance for the next generation OmniPod System from the FDA. The new OmniPod System is more than one-third smaller and one-quarter lighter than the original model, while maintaining the same features and operating capabilities. The Company began selling the new OmniPod System to new users in the first quarter of 2013 and began converting the existing customer base in the second quarter of 2013. At December 31, 2013, the Company completed the transition to the new OmniPod System.</font></div></div>
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	55102000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3388000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	96393000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7307000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10991000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48969000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29059000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3348000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25452000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-45831000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-44974000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-51867000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-10519000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-21290000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-2500000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-10665000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-12417000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-10194000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-14780000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-14476000	USD
CY2013	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Customer
CY2012	us-gaap	Operating Expenses OperatingExpenses	128307000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	141536000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	109179000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-42467000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-29135000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-35971000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	17515000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1433000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2012000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2012000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1934000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1974000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	8150000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2900000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2261000	USD
CY2012Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	0	USD
CY2013Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	1351000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2202000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1825000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1943000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1867000	USD
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1351000	USD
CY2012	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2011	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15684000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15739000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14576000	USD
CY2011	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	946000	USD
CY2012	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1539000	USD
CY2013	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3265000	USD
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	37855000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11114000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7307000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10991000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5940000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4482000	USD
CY2011	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	138783000	USD
CY2012	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
CY2013	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4927000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	102652000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5460000	USD
CY2012Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1992000	USD
CY2011Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1960000	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3090000	USD
CY2013Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1173000	USD
CY2012Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	863000	USD
CY2013Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	1917000	USD
CY2012Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	1129000	USD
CY2012	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2634000	USD
CY2013	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2967000	USD
CY2012	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	2666000	USD
CY2013	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4065000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	53349000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	66818000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25422000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32356000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4741000	USD
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3165000	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3409000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	100000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	100000	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	994000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2000000	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	88195000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21765000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24359000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21863000	USD
CY2013	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-3265000	USD
CY2011	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-946000	USD
CY2012	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1538000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-481551000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-526525000	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	247084000	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	152255000	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	211369000	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	68533000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	60092000	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	61103000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	57356000	USD
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	57828000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	51035000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	47754000	USD
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	54752000	USD
CY2013Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3928000	USD
CY2012Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3965000	USD
CY2012	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52708000	USD
CY2011	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43233000	USD
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	55694000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	9920000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	7734000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	12683000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1115339	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.42
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	17820000	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8800000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9000000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	83904	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	282400	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.04
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.75
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.42
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	37742000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2502190	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1828613	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.46
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.51
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	33349000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1562587	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.67
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	19.94
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.79
CY2013Q4	us-gaap	Share Price SharePrice	37.10
CY2012Q4	us-gaap	Share Price SharePrice	21.22
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	26413000	USD
CY2011	us-gaap	Stock Issued1 StockIssued1	24432000	USD
CY2012	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2013	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	872073	shares
CY2011	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	24188000	USD
CY2013	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	13326000	USD
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	445000	USD
CY2012	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	392000	USD
CY2011	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	253000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	92812000	USD
CY2013Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	97800000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4592000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9461000	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5242000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	44176000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	124597000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	66231000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	82735000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates in Preparation of Financial Statements</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting periods. The most significant estimates used in these financial statements include the valuation of stock-based compensation expense, accounts receivable, inventories, goodwill, deferred revenue, and equity instruments, the lives of property and equipment and intangible assets, as well as warranty and doubtful accounts allowance reserve calculations. Actual results may differ from those estimates.</font></div></div>
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12400000	USD
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46689880	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54010887	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	47924324	shares
CY2013Q4	podd	Accrued Supplier Charges AccruedSupplierCharges	1850000	USD
CY2012Q4	podd	Accrued Supplier Charges AccruedSupplierCharges	1752000	USD
CY2013Q4	podd	Accrued Training Current AccruedTrainingCurrent	717000	USD
CY2012Q4	podd	Accrued Training Current AccruedTrainingCurrent	455000	USD
CY2013	podd	Capital Leasesof Lessee Contingent Rentals Effective Interest Rate CapitalLeasesofLesseeContingentRentalsEffectiveInterestRate	0.17
CY2013Q4	podd	Debt Instrument Modified Debt Unamortized Discount DebtInstrumentModifiedDebtUnamortizedDiscount	52400000	USD
CY2012Q4	podd	Debt Instrument Modified Debt Unamortized Discount DebtInstrumentModifiedDebtUnamortizedDiscount	52400000	USD
CY2013	podd	Deferred Compensation Arrangement With Individual Required Service Period DeferredCompensationArrangementWithIndividualRequiredServicePeriod	P4Y
CY2012	podd	Deferred Compensation Arrangement With Individual Required Service Period DeferredCompensationArrangementWithIndividualRequiredServicePeriod	P4Y
CY2011	podd	Deferred Compensation Arrangement With Individual Required Service Period DeferredCompensationArrangementWithIndividualRequiredServicePeriod	P4Y
CY2011	podd	Deferred Income Tax Benefit DeferredIncomeTaxBenefit	-11289000	USD
CY2012	podd	Deferred Income Tax Benefit DeferredIncomeTaxBenefit	0	USD
CY2013	podd	Deferred Income Tax Benefit DeferredIncomeTaxBenefit	0	USD
CY2013Q4	podd	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	1675000	USD
CY2012Q4	podd	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	2357000	USD
CY2012Q4	podd	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	2020000	USD
CY2013Q4	podd	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	1672000	USD
CY2012Q4	podd	Deferred Tax Liabilities Gross DeferredTaxLiabilitiesGross	25278000	USD
CY2013Q4	podd	Deferred Tax Liabilities Gross DeferredTaxLiabilitiesGross	18996000	USD
CY2013	podd	Defined Contribution Plan Employer Discretionary Match Percentage DefinedContributionPlanEmployerDiscretionaryMatchPercentage	0.50
CY2011	podd	Defined Contribution Plan Employer Discretionary Match Percentage DefinedContributionPlanEmployerDiscretionaryMatchPercentage	0.50
CY2012	podd	Defined Contribution Plan Employer Discretionary Match Percentage DefinedContributionPlanEmployerDiscretionaryMatchPercentage	0.50
CY2013	podd	Defined Contribution Plan Service Period DefinedContributionPlanServicePeriod	P30D
CY2013	podd	Dollarequivalentofsharesissuedatconversion Dollarequivalentofsharesissuedatconversion	300000	USD
CY2013Q4	podd	Fair Value Assumption Bond Call Strike Price FairValueAssumptionBondCallStrikePrice	100
CY2013	podd	Fair Value Assumption Conversion Price FairValueAssumptionConversionPrice	26.20
CY2013	podd	Fair Value Assumption Coupon Rate FairValueAssumptionCouponRate	0.0375
CY2013	podd	Fair Value Assumptions Bond Yield FairValueAssumptionsBondYield	0.0861
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001145197
CY2013	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	10425000	USD
CY2011	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	4697000	USD
CY2012	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	2999000	USD
CY2012Q4	podd	Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance	2	Customer
CY2013Q4	podd	Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance	2	Customer
CY2013Q4	podd	Number Of Financial Institution NumberOfFinancialInstitution	2	Location
CY2013Q4	podd	Number Of Single Source Suppliers NumberOfSingleSourceSuppliers	1	Customer
CY2012Q4	podd	Number Of Single Source Suppliers NumberOfSingleSourceSuppliers	1	Customer
CY2013	podd	Percentage Of Accounts Payable PercentageOfAccountsPayable	0.36
CY2012	podd	Percentage Of Accounts Payable PercentageOfAccountsPayable	0.19
CY2013Q2	podd	Principalamountofdebtrepaid Principalamountofdebtrepaid	2000000	USD
CY2013	podd	Product Warranty Term ProductWarrantyTerm	P4Y
CY2013	podd	Repayment Periodfor Capital Lease Obligations RepaymentPeriodforCapitalLeaseObligations	P36M
CY2013Q2	podd	Repaymentofremainingprinicpalamountincludinginterest Repaymentofremainingprinicpalamountincludinginterest	2100000	USD
CY2013	podd	Return Period ReturnPeriod	P45D
CY2013	podd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures	0.16
CY2013	podd	Stock Price Change Percent StockPriceChangePercent	0.75
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Trading Symbol TradingSymbol	PODD
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55061744	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	1700000000	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	INSULET CORP
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No

Files In Submission

Name	View Source	Status
0001145197-14-000013-index-headers.html	Edgar Link	pending
0001145197-14-000013-index.html	Edgar Link	pending
0001145197-14-000013.txt	Edgar Link	pending
0001145197-14-000013-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
podd-20131231.xml	Edgar Link	completed
podd-20131231.xsd	Edgar Link	pending
podd-20131231_cal.xml	Edgar Link	unprocessable
podd-20131231_def.xml	Edgar Link	unprocessable
podd-20131231_lab.xml	Edgar Link	unprocessable
podd-20131231_pre.xml	Edgar Link	unprocessable
podd20131231chart.jpg	Edgar Link	pending
poddex1021_20131231.htm	Edgar Link	pending
poddex1032_20131231.htm	Edgar Link	pending
poddex1033_20131231.htm	Edgar Link	pending
poddex1034_20131231.htm	Edgar Link	pending
poddex1035_20131231.htm	Edgar Link	pending
poddex1036_20131231.htm	Edgar Link	pending
poddex1037_20131231.htm	Edgar Link	pending
poddex104_20131231.htm	Edgar Link	pending
poddex105_20131231.htm	Edgar Link	pending
poddex106_20131231.htm	Edgar Link	pending
poddex107_20131231.htm	Edgar Link	pending
poddex211_20131231.htm	Edgar Link	pending
poddex231_20131231.htm	Edgar Link	pending
poddex311_20131231.htm	Edgar Link	pending
poddex312_20131231.htm	Edgar Link	pending
poddex321_20131231.htm	Edgar Link	pending
podd_20131231x10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODD
INSULET CORP Stock $podd

2014 Q1 Form 10-K Financial Statement

#000114519714000013 Filed on February 28, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD INSULET CORP Stock $podd

2014 Q1 Form 10-K Financial Statement

#000114519714000013 Filed on February 28, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD
INSULET CORP Stock $podd